Внесок користувача
- 17:49, 22 лютого 2017 (різн. • історія) . . (+3322) . . Н Despite not showing differences in MMP activation, data demonstrated that b1kd, but not b3kd cells showed a small but significant reduction in 2D gelatin degradation compared to control cells (Створена сторінка: Final results are expressed as (mean6SEM) share of specified cells from all cells isolated (n = 10 mice , p = .05).Determine three. b1 and b3 integrins differen...) (поточна)
- 16:21, 20 лютого 2017 (різн. • історія) . . (+164) . . м The findings suggest that ECFC tubule formation in the presence of FBS is, at least in part, VDR dependent (поточна)
- 18:15, 16 лютого 2017 (різн. • історія) . . (+28) . . м In our implementation, all the reaction steps were considered reversible except for the ATP hydrolytic step, which is irreversible (поточна)
- 18:14, 16 лютого 2017 (різн. • історія) . . (+3336) . . Н In our implementation, all the reaction steps were considered reversible except for the ATP hydrolytic step, which is irreversible (Створена сторінка: This intricate is considered to resemble structurally the standard transition state conformation shaped with Pi. In our implementation, all the response methods...)
- 16:48, 14 лютого 2017 (різн. • історія) . . (-40) . . м HIF1 has been regarded as a metabolic regulator by its known transcriptional regulation of various metabolic targets including the glucose transporter (поточна)
- 16:47, 14 лютого 2017 (різн. • історія) . . (+3131) . . Н HIF1 has been regarded as a metabolic regulator by its known transcriptional regulation of various metabolic targets including the glucose transporter (Створена сторінка: HIF1 has been regarded as a metabolic regulator by its recognized transcriptional regulation of numerous metabolic targets which includes the glucose transporte...)
- 14:13, 14 лютого 2017 (різн. • історія) . . (+3694) . . Н Recent evidence suggests that the HIF1a locus is selectively lost in ccRCC tumors during progression to higher stages (Створена сторінка: Current evidence suggests that the HIF1a locus is selectively dropped in ccRCC tumors throughout progression to greater phases [18]. Carcinoma is more and more...) (поточна)
- 14:47, 13 лютого 2017 (різн. • історія) . . (-73) . . м In contrast however, our results also indicate that high concentrations of endoxifen enhance cortical bone thickness in ovariectomized mice (поточна)
- 11:48, 13 лютого 2017 (різн. • історія) . . (+6306) . . Н Here, we have demonstrated that an anti-cancer dose of endoxifen enhances bone mineral density and content throughout the skeleton in an ovariectomized mouse model (Here, we have demonstrated that an anti-cancer dose of endoxifen enhances bone mineral density and content throughout the skeleton in an ovariectomized mouse model) (поточна)
- 19:47, 9 лютого 2017 (різн. • історія) . . (+3772) . . Н Nevertheless some PKC inhibitors do not avoid the suppression of the M-recent induced by muscarinic agonists which once led to an exclusion of PKC from the record of prospect mediators (Створена сторінка: The variations detected in the kinase area of VRK proteins indicate that they might be really ideal for developing [http://www.fibran.gr/forum/discussion/201868...) (поточна)
- 17:32, 9 лютого 2017 (різн. • історія) . . (+8471) . . Н These AGC kinases could be challenging but the approaches now accessible for structural reports of equally MRCK and ROCK kinases need to enable iterative drug development techniques (These AGC kinases could be challenging but the approaches now accessible for structural reports of equally MRCK and ROCK kinases need to enable iterative drug development techniques) (поточна)